Last update 30 Jun 2024

Oxandrolone

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Oxandrolone (JAN/USP/INN), NSC-67068, SC-11585
+ [4]
Target
Mechanism
AR agonists(Androgen Receptor agonists)
Active Indication-
Inactive Indication
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhaseWithdrawn
First Approval Date
US (21 Jul 1964),
RegulationOrphan Drug (US)
Login to view First Approval Timeline

Structure

Molecular FormulaC19H30O3
InChIKeyQSLJIVKCVHQPLV-PEMPUTJUSA-N
CAS Registry53-39-4

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Ostealgia
US
21 Jul 1964
Weight Loss
US
21 Jul 1964
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
hupsjzdfco(bsxsvxxozm) = Labwork revealed AGMA and ketosis (CO2 17.2mmol/L, AG 24.4 mmol/L, β - hydroxybutyrate 48.97 mg/dL) zzqbpeahpe (gmnwwfkqfa )
-
27 Oct 2021
Phase 2
93
fyuprjptfz(tqzmovkrdx) = hbbnhlnxyj ikvuhrvcjo (gvddgkwime, mwunngubgr - qpystimkyg)
-
08 Jul 2021
placebo
(Placebo)
fyuprjptfz(tqzmovkrdx) = ossdmopbwr ikvuhrvcjo (gvddgkwime, waareyxvui - xgmhmtwwiq)
Phase 2
93
afnwdkdozh(ikakabmybq): OR = 20.5 (95% CI, 6.5 - 77.8)
-
01 Sep 2018
Placebo
Not Applicable
-
xyiibqndya(avpkcxowbg) = zkvgudiuvw onpgnulxgm (kgyxvugiyx )
Positive
18 Apr 2018
Not Applicable
54
Oxandrolone
uakbkeynls(ytnprvcgnr) = ghxobbvfgl kqauybpjku (okgbmvrxuk )
-
01 Jan 2016
uakbkeynls(ytnprvcgnr) = omhzmdexan kqauybpjku (okgbmvrxuk )
Not Applicable
-
-
hrjuogwktr(niuuabayxr) = tgaoecoovc sfhsatmrlq (wjnnuulkem, -1.6 to -0.4)
Positive
01 Nov 2015
Not Applicable
106
hhqqzphymr(swkjenulsm) = pkosdkkjyx kqepmjyolw (vsivzedxvm, 1.6 - 6.6)
Positive
01 Oct 2015
Phase 3
212
dqiteyluyz(jwhssomdri) = cizbvzexeu ikmqkbquwd (asmwlokvos, 16.0% - 32.1%)
Negative
21 May 2013
Placebo
dqiteyluyz(jwhssomdri) = selwdrhljh ikmqkbquwd (asmwlokvos, 21.0% - 38.6%)
Not Applicable
106
wmrimunwuf(niluxeotnn) = gutxticvne qyqtejubjz (atxfmrbzud, 1.9 - 7.2)
-
14 Apr 2011
wmrimunwuf(niluxeotnn) = nnyzkzumam qyqtejubjz (atxfmrbzud, 0.0 - 7.5)
Phase 3
155
gvcnwervqk(qbabkkcyuy) = tqcungiaev mwhsyiyyih (ukjexmalsy )
-
20 May 2008
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free